Antiretroviral Treatment (ART) for Patients Infected With HIV

Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course HIV Safety for Florida Clinical Laboratory Personnel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HIV Safety for Florida Clinical Laboratory Personnel (online CE course)
Antiretroviral Treatment (ART) for Patients Infected With HIV

An important step before the selection of antiretroviral treatment, or ART, is to test for transmitted resistance. According to the AIDS Education and Training Centers National Resource Center, 6-16% of patients infected with HIV will demonstrate transmitted ART resistance. Problems arise while treating patients with ART resistance due to lower treatment response rates which can negatively affect the patient's treatment outcome.
Antiretroviral treatments can improve and preserve immune function in most patients with virologic suppression. The AIDS Education and Training Centers National Resource Center describes the benefits in using such treatments which include:
  • Better immunologic responses and better clinical outcomes
  • Reduction in AIDS- and non-AIDS-associated morbidity and mortality
  • Reduction in HIV-associated inflammation and associated complications
  • Reduction in HIV transmission
  • Recommended ARV combinations are considered to be durable and tolerable